TABLE 1

Basic characteristics

Moderate (n = 10)Severe (n = 16)Critical (n = 77)P value*
Female5 (56%)8 (53%)31 (42%)0.64
Age58.5 (53.0, 70.2)57.0 (52.7, 71.9)69.4 (59.1, 76.7)0.095
BMI26.6 (25.2, 29.2)25.8 (25.2, 31.2)28.6 (24.8, 31.9)0.45
Days since disease onset4.5 (1.0, 6.5)7.0 (6.0, 13.0)7.0 (4.0, 10.0)0.13
Clinical parameters at presentation
FiO2 (%)21 (21, 21)21 (21, 22)36 (28, 44)<0.001
Oxygen required2 (20%)4 (25%)61 (79%)<0.001
sNose mask2441
Venturi mask 40%/60%006
Nonrebreathing mask0014
Respiratory rate (/min)17 (16, 18)22 (17, 24)24 (20, 30)0.002
SBP (mmHg)137 (125, 170)134 (123, 152)134 (119, 149)0.69
DBP (mmHg)78 (63, 87)80 (62, 86)79 (69, 85)0.93
HR (bpm)89 (76, 101)80 (70, 94)89 (79, 105)0.075
Temperature (°C)37.5 (37.2, 38.6)38.1 (37.0, 38.6)38.0 (37.2, 38.4)0.94
CRP (g/L)13.5 (5.5, 39.0)54.0 (42.0, 63.0)95.0 (34.5, 152.5)0.003
Total leukocyte count (×109/L)5.7 (4.4, 6.4)6.0 (4.5, 7.0)6.8 (5.1, 10.3)0.087
Arterial saturation0.97 (0.97, 0.98)0.96 (0.95, 0.98)0.94 (0.92, 0.96)0.061
Clinical admission
Length of hospital stay (days)5.0 (3.0, 7.5)13.0 (6.0, 20.0)<0.001
ICU admission0 (0%)22 (36%)0.006
Mortality1 (6%)21 (27%)0.072
Samples
Samples10 (100%)10 (63%)60 (78%)
Moderate (n = 10)Severe (n = 16)Critical (n = 77)P value*
Female5 (56%)8 (53%)31 (42%)0.64
Age58.5 (53.0, 70.2)57.0 (52.7, 71.9)69.4 (59.1, 76.7)0.095
BMI26.6 (25.2, 29.2)25.8 (25.2, 31.2)28.6 (24.8, 31.9)0.45
Days since disease onset4.5 (1.0, 6.5)7.0 (6.0, 13.0)7.0 (4.0, 10.0)0.13
Clinical parameters at presentation
FiO2 (%)21 (21, 21)21 (21, 22)36 (28, 44)<0.001
Oxygen required2 (20%)4 (25%)61 (79%)<0.001
sNose mask2441
Venturi mask 40%/60%006
Nonrebreathing mask0014
Respiratory rate (/min)17 (16, 18)22 (17, 24)24 (20, 30)0.002
SBP (mmHg)137 (125, 170)134 (123, 152)134 (119, 149)0.69
DBP (mmHg)78 (63, 87)80 (62, 86)79 (69, 85)0.93
HR (bpm)89 (76, 101)80 (70, 94)89 (79, 105)0.075
Temperature (°C)37.5 (37.2, 38.6)38.1 (37.0, 38.6)38.0 (37.2, 38.4)0.94
CRP (g/L)13.5 (5.5, 39.0)54.0 (42.0, 63.0)95.0 (34.5, 152.5)0.003
Total leukocyte count (×109/L)5.7 (4.4, 6.4)6.0 (4.5, 7.0)6.8 (5.1, 10.3)0.087
Arterial saturation0.97 (0.97, 0.98)0.96 (0.95, 0.98)0.94 (0.92, 0.96)0.061
Clinical admission
Length of hospital stay (days)5.0 (3.0, 7.5)13.0 (6.0, 20.0)<0.001
ICU admission0 (0%)22 (36%)0.006
Mortality1 (6%)21 (27%)0.072
Samples
Samples10 (100%)10 (63%)60 (78%)
*

P value using χ2, Kruskal-Wallis, or Mann-Whitney U-test where appropriate.

**

Categorical values are described as N (%) and continuous values are described as median with interquartile range.

***

Abbreviations: BMI—body mass index; SBP—systolic blood pressure; DBP—diastolic blood pressure; CRP—C-reactive protein; and ICU—intensive care unit.

****

Number of missing values: BMI—12%; onset of symptoms—12%; respiratory rate—16%; systolic blood pressure—4%; diastolic blood pressure 5%; pulse rate—8%; temperature—11%; CRP—18%; total leukocyte count—17%; arterial saturation—43%; absolute cell counts—2%; and all others: no missing values.

TABLE 1

Basic characteristics

Moderate (n = 10)Severe (n = 16)Critical (n = 77)P value*
Female5 (56%)8 (53%)31 (42%)0.64
Age58.5 (53.0, 70.2)57.0 (52.7, 71.9)69.4 (59.1, 76.7)0.095
BMI26.6 (25.2, 29.2)25.8 (25.2, 31.2)28.6 (24.8, 31.9)0.45
Days since disease onset4.5 (1.0, 6.5)7.0 (6.0, 13.0)7.0 (4.0, 10.0)0.13
Clinical parameters at presentation
FiO2 (%)21 (21, 21)21 (21, 22)36 (28, 44)<0.001
Oxygen required2 (20%)4 (25%)61 (79%)<0.001
sNose mask2441
Venturi mask 40%/60%006
Nonrebreathing mask0014
Respiratory rate (/min)17 (16, 18)22 (17, 24)24 (20, 30)0.002
SBP (mmHg)137 (125, 170)134 (123, 152)134 (119, 149)0.69
DBP (mmHg)78 (63, 87)80 (62, 86)79 (69, 85)0.93
HR (bpm)89 (76, 101)80 (70, 94)89 (79, 105)0.075
Temperature (°C)37.5 (37.2, 38.6)38.1 (37.0, 38.6)38.0 (37.2, 38.4)0.94
CRP (g/L)13.5 (5.5, 39.0)54.0 (42.0, 63.0)95.0 (34.5, 152.5)0.003
Total leukocyte count (×109/L)5.7 (4.4, 6.4)6.0 (4.5, 7.0)6.8 (5.1, 10.3)0.087
Arterial saturation0.97 (0.97, 0.98)0.96 (0.95, 0.98)0.94 (0.92, 0.96)0.061
Clinical admission
Length of hospital stay (days)5.0 (3.0, 7.5)13.0 (6.0, 20.0)<0.001
ICU admission0 (0%)22 (36%)0.006
Mortality1 (6%)21 (27%)0.072
Samples
Samples10 (100%)10 (63%)60 (78%)
Moderate (n = 10)Severe (n = 16)Critical (n = 77)P value*
Female5 (56%)8 (53%)31 (42%)0.64
Age58.5 (53.0, 70.2)57.0 (52.7, 71.9)69.4 (59.1, 76.7)0.095
BMI26.6 (25.2, 29.2)25.8 (25.2, 31.2)28.6 (24.8, 31.9)0.45
Days since disease onset4.5 (1.0, 6.5)7.0 (6.0, 13.0)7.0 (4.0, 10.0)0.13
Clinical parameters at presentation
FiO2 (%)21 (21, 21)21 (21, 22)36 (28, 44)<0.001
Oxygen required2 (20%)4 (25%)61 (79%)<0.001
sNose mask2441
Venturi mask 40%/60%006
Nonrebreathing mask0014
Respiratory rate (/min)17 (16, 18)22 (17, 24)24 (20, 30)0.002
SBP (mmHg)137 (125, 170)134 (123, 152)134 (119, 149)0.69
DBP (mmHg)78 (63, 87)80 (62, 86)79 (69, 85)0.93
HR (bpm)89 (76, 101)80 (70, 94)89 (79, 105)0.075
Temperature (°C)37.5 (37.2, 38.6)38.1 (37.0, 38.6)38.0 (37.2, 38.4)0.94
CRP (g/L)13.5 (5.5, 39.0)54.0 (42.0, 63.0)95.0 (34.5, 152.5)0.003
Total leukocyte count (×109/L)5.7 (4.4, 6.4)6.0 (4.5, 7.0)6.8 (5.1, 10.3)0.087
Arterial saturation0.97 (0.97, 0.98)0.96 (0.95, 0.98)0.94 (0.92, 0.96)0.061
Clinical admission
Length of hospital stay (days)5.0 (3.0, 7.5)13.0 (6.0, 20.0)<0.001
ICU admission0 (0%)22 (36%)0.006
Mortality1 (6%)21 (27%)0.072
Samples
Samples10 (100%)10 (63%)60 (78%)
*

P value using χ2, Kruskal-Wallis, or Mann-Whitney U-test where appropriate.

**

Categorical values are described as N (%) and continuous values are described as median with interquartile range.

***

Abbreviations: BMI—body mass index; SBP—systolic blood pressure; DBP—diastolic blood pressure; CRP—C-reactive protein; and ICU—intensive care unit.

****

Number of missing values: BMI—12%; onset of symptoms—12%; respiratory rate—16%; systolic blood pressure—4%; diastolic blood pressure 5%; pulse rate—8%; temperature—11%; CRP—18%; total leukocyte count—17%; arterial saturation—43%; absolute cell counts—2%; and all others: no missing values.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close